Location History:
- Pacific Beach, CA (US) (2004)
- San Diego, CA (US) (1997 - 2006)
Company Filing History:
7 out of 656 
6 out of 9 
1 out of 53 Years Active: 1997-2006
Title: **James G Respess: Innovator in Recombinant Retroviral Technologies**
Introduction
James G Respess, based in San Diego, CA, is a prominent inventor known for his significant contributions to the field of recombinant retroviral technologies. With a portfolio of 19 patents, Respess's work focuses on advancing methods for producing safer and more effective retroviral vector particles. His innovations have the potential to improve gene therapy and treatment protocols for various disorders.
Latest Patents
Among Respess's latest patents, one notable invention revolves around **Packaging cells**. This invention enables the production of recombinant retroviruses from producer cells that are both safer and yield higher titers compared to traditional methods. The patent also includes methodologies for creating helper cells that, when a recombinant retrovirus genome is introduced, result in particles specifically targeted to certain cell types. Additionally, the invention encompasses methods for developing recombinant retrovirus systems designed to infect specific cell types, such as tumors. Among the advantages of these methods is the ability to produce recombinant retroviruses that integrate into a limited number of locations within the host genome and the production of viral particles from transgenic animals. Furthermore, methods for administering recombinant gene delivery vehicles are described, aimed at achieving measurable levels of therapeutic proteins, nucleic acid molecules, or enzymatic products in human bodily fluids or cells.
Career Highlights
James G Respess has built an impressive career by collaborating with significant companies in the biotechnology field. Notable among these are Chiron Corporation and Chiron Viagene, Inc. His work has been instrumental in pioneering new approaches in gene therapy and has set benchmarks for novel methods in retroviral vector development.
Collaborations
During his career, Respess worked alongside esteemed colleagues, including Douglas J Jolly and Paul K Laikind. Together, they have collaborated on various projects, contributing to advancements that have been pivotal in the biotech industry.
Conclusion
James G Respess exemplifies innovation in biotechnology, particularly in the realm of recombinant retroviruses. His extensive patent portfolio reflects a deep commitment to enhancing gene therapy methods, which hold promise for addressing genetic disorders and improving patients' health outcomes. Through his work, Respess continues to influence the landscape of medical research and treatment methodologies.